γδ T 细胞调节小细胞肺癌中的抗肿瘤免疫
γδ T cells modulate anti-tumor immunity in small cell lung cancer.
我们的发现表明,活化的γδ T细胞可能是SCLC治疗的有价值靶点。
英文原题:Seven subsets, two fates: mouse γδ T cells in cancer immunity.
γδ T细胞在癌症中作为抗肿瘤发生防御者的重要性,早在20多年前就已确立。
γδ T 细胞作为抗肿瘤发生的防御者,其在癌症中的重要性早在 20 多年前就已确立。自那时起,利用小鼠癌症模型开展的研究通过细化单个 γδ T 细胞亚群在特定癌症类型中的作用,揭示了肿瘤相关 γδ T 细胞的非均一性图景。在本综述中,我们讨论了突出 Vγ1+、Vγ4+、Vγ5+、Vγ6+ 和 Vγ7+ 细胞在整个癌症进展过程中独特贡献的数据。我们深入探讨了它们对肿瘤的应答,包括保护性和致病性功能。我们审视了这些小鼠免疫细胞亚群塑造肿瘤发展和扩散的机制如何可被用于癌症患者的治疗目的。
The importance of γδ T cells in cancer, as defenders against tumorigenesis, was established more than 2 decades ago. Since that time, research using mouse models of cancer has brought to light a nonuniform view of tumor-associated γδ T cells by providing granularity into the role of individual γδ T cell subsets in specific cancer types. In this review, we discuss data that highlight the unique contributions of Vγ1 + , Vγ4 + , Vγ5 + , Vγ6 + , and Vγ7 + cells throughout cancer progression. We delve into their responses to tumors, including both protective and pathogenic functions. We examine how the mechanisms by which these mouse immune cell subsets shape tumor development and spread can be exploited for therapeutic purposes in people with cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。